Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
MON
Monsanto Co
MON
|
+$1.03B |
| 2 |
Cisco
CSCO
|
+$872M |
| 3 |
Alibaba
BABA
|
+$721M |
| 4 |
AbbVie
ABBV
|
+$560M |
| 5 |
Ventas
VTR
|
+$540M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$1.65B |
| 2 |
Biogen
BIIB
|
+$907M |
| 3 |
Yum! Brands
YUM
|
+$897M |
| 4 |
Oracle
ORCL
|
+$778M |
| 5 |
BHI
Baker Hughes
BHI
|
+$557M |
Sector Composition
| 1 | Healthcare | 21.41% |
| 2 | Technology | 12.87% |
| 3 | Industrials | 11.05% |
| 4 | Communication Services | 10.38% |
| 5 | Consumer Staples | 8.5% |
